Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-16

FDA Approved: ACETAZOLAMIDE — Supplemental Application (TRUPHARMA, LLC)

View source ↗

Summary

FDA approved a supplemental application for acetazolamide from TRUPHARMA, LLC under ANDA 211372. This action updates the approval status of this generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)